Inaktiver Wert

Gelesis Inc Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Gelesis Expands Ongoing Weight Loss Study to Serve as U.S. Pivotal Trial, Significantly Accelerating Development Timeline	27.07.15
Gelesis Presents Additional Data at European Congress on Obesity	22.05.15

Manager	Titel	Alter	Seit
David Pass COO	Chief Operating Officer	56	01.09.16
Angelo Tremblay PRN	Corporate Officer/Principal	-	-
Cosimo Saponaro PRN	Corporate Officer/Principal	-	-

Aufsichtsräte	Titel	Alter	Seit
Clayton Christopher BRD	Director/Board Member	51	-
Kathryn Cavanaugh BRD	Director/Board Member	50	01.01.22
Alison Bauerlein BRD	Director/Board Member	42	05.01.22

Sektor

	% 1. Jan.	Kap.
SAMSUNG BIOLOGICS CO.,LTD.	+1.45%	40.51 Mrd.
BIOGEN INC.	-15.94%	31.67 Mrd.
UCB	+52.66%	24.62 Mrd.
BIOMARIN PHARMACEUTICAL INC.	-14.50%	15.65 Mrd.
INCYTE CORPORATION	-14.38%	12.07 Mrd.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.12%	11.97 Mrd.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.56%	11.61 Mrd.
SWEDISH ORPHAN BIOVITRUM AB	+4.87%	8.81 Mrd.
INNOVENT BIOLOGICS, INC.	-4.33%	8.5 Mrd.